222 related articles for article (PubMed ID: 33078525)
1. Polyphenol-Based Nanomedicine Evokes Immune Activation for Combination Cancer Treatment.
Zhang Z; Sang W; Xie L; Li W; Li B; Li J; Tian H; Yuan Z; Zhao Q; Dai Y
Angew Chem Int Ed Engl; 2021 Jan; 60(4):1967-1975. PubMed ID: 33078525
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer.
Wu H; Du X; Xu J; Kong X; Li Y; Liu D; Yang X; Ye L; Ji J; Xi Y; Zhai G
Acta Biomater; 2023 Feb; 157():551-565. PubMed ID: 36513248
[TBL] [Abstract][Full Text] [Related]
3. High Affinity of Chlorin e6 to Immunoglobulin G for Intraoperative Fluorescence Image-Guided Cancer Photodynamic and Checkpoint Blockade Therapy.
Xu J; Yu S; Wang X; Qian Y; Wu W; Zhang S; Zheng B; Wei G; Gao S; Cao Z; Fu W; Xiao Z; Lu W
ACS Nano; 2019 Sep; 13(9):10242-10260. PubMed ID: 31397999
[TBL] [Abstract][Full Text] [Related]
4. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
[TBL] [Abstract][Full Text] [Related]
5. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy.
Liu H; Hu Y; Sun Y; Wan C; Zhang Z; Dai X; Lin Z; He Q; Yang Z; Huang P; Xiong Y; Cao J; Chen X; Chen Q; Lovell JF; Xu Z; Jin H; Yang K
ACS Nano; 2019 Nov; 13(11):12638-12652. PubMed ID: 31625721
[TBL] [Abstract][Full Text] [Related]
7. PEGylated mesoporous Bi
Sun L; Hou M; Zhang L; Qian D; Yang Q; Xu Z; Kang Y; Xue P
Nanomedicine; 2019 Apr; 17():1-12. PubMed ID: 30654184
[TBL] [Abstract][Full Text] [Related]
8. Activating CD8
Wang B; Zhou J; Li R; Tang D; Cao Z; Xu C; Xiao H
Adv Mater; 2024 May; 36(21):e2311640. PubMed ID: 38341667
[TBL] [Abstract][Full Text] [Related]
9. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations.
Jiang Y; Chen M; Nie H; Yuan Y
Hum Vaccin Immunother; 2019; 15(5):1111-1122. PubMed ID: 30888929
[TBL] [Abstract][Full Text] [Related]
10. Dendritic polymer-functionalized nanomedicine potentiates immunotherapy via lethal energy crisis-induced PD-L1 degradation.
Li X; Duan Z; Li Z; Gu L; Li Y; Gong Q; Gu Z; Luo K
Biomaterials; 2023 Nov; 302():122294. PubMed ID: 37657175
[TBL] [Abstract][Full Text] [Related]
11. A Multifunctional Biomimetic Nanoplatform for Relieving Hypoxia to Enhance Chemotherapy and Inhibit the PD-1/PD-L1 Axis.
Zou MZ; Liu WL; Li CX; Zheng DW; Zeng JY; Gao F; Ye JJ; Zhang XZ
Small; 2018 Jul; 14(28):e1801120. PubMed ID: 29882235
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer.
Zhang R; Zhu Z; Lv H; Li F; Sun S; Li J; Lee CS
Small; 2019 Dec; 15(49):e1903881. PubMed ID: 31702880
[TBL] [Abstract][Full Text] [Related]
13. A Metal-Polyphenol-Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy.
Ren Z; Sun S; Sun R; Cui G; Hong L; Rao B; Li A; Yu Z; Kan Q; Mao Z
Adv Mater; 2020 Feb; 32(6):e1906024. PubMed ID: 31834662
[TBL] [Abstract][Full Text] [Related]
14. Cytokines as potential combination agents with PD-1/PD-L1 blockade for cancer treatment.
Rahimi Kalateh Shah Mohammad G; Ghahremanloo A; Soltani A; Fathi E; Hashemy SI
J Cell Physiol; 2020 Jul; 235(7-8):5449-5460. PubMed ID: 31970790
[TBL] [Abstract][Full Text] [Related]
15. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
16. Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing.
Wang R; He Z; Cai P; Zhao Y; Gao L; Yang W; Zhao Y; Gao X; Gao F
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13964-13972. PubMed ID: 30912920
[TBL] [Abstract][Full Text] [Related]
17. Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action.
Zhang N; Tu J; Wang X; Chu Q
Immunotherapy; 2019 Apr; 11(5):429-441. PubMed ID: 30698054
[TBL] [Abstract][Full Text] [Related]
18. Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature.
Bao R; Wang Y; Lai J; Zhu H; Zhao Y; Li S; Li N; Huang J; Yang Z; Wang F; Liu Z
Mol Pharm; 2019 Jan; 16(1):339-348. PubMed ID: 30452269
[TBL] [Abstract][Full Text] [Related]
19. Oxygen-Enriched Metal-Phenolic X-Ray Nanoprocessor for Cancer Radio-Radiodynamic Therapy in Combination with Checkpoint Blockade Immunotherapy.
Sang W; Xie L; Wang G; Li J; Zhang Z; Li B; Guo S; Deng CX; Dai Y
Adv Sci (Weinh); 2021 Feb; 8(4):2003338. PubMed ID: 33643804
[TBL] [Abstract][Full Text] [Related]
20. A Three-in-One Immunotherapy Nanoweapon via Cascade-Amplifying Cancer-Immunity Cycle against Tumor Metastasis, Relapse, and Postsurgical Regrowth.
Li Q; Zhang D; Zhang J; Jiang Y; Song A; Li Z; Luan Y
Nano Lett; 2019 Sep; 19(9):6647-6657. PubMed ID: 31409072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
